Some ADC drugs targeting CD44, such as conjugation of hyaluronan with irinotecan (96), cisplatin (97), and apoferritin (98), are effective in reducing or even eliminating stem cells in lung cancer. This evidence concerns the gene CD44 and lung carcinoma.